Related Experiment Video
Updated: Jun 8, 2026

In Vivo Mouse Model of Spinal Implant Infection
Published on: June 23, 2020
Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with
Luis A Marcos1, Bernard C Camins
1Division of Infection Diseases, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8051, Saint Louis, MO 63110-1093, USA. lmarcos@dom.wustl.edu
Abstract:
Emerging infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) isolates are more likely to be associated with treatment failures than infections caused by other types of S. aureus. We present a case of pacemaker lead infective endocarditis caused by a non-daptomycin-susceptible strain of VISA. After 8 weeks of parenteral telavancin therapy, the patient achieved microbiological and clinical cure.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Clinical Significance of Antibiotic Resistance
Mitral Stenosis III: Medical Management
